Trials / Completed
CompletedNCT00976274
Korean Red Ginseng and Metabolic Syndrome
Effects of Korean Red Ginseng on Cardiovascular Risks in Subjects With Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- The Korean Society of Ginseng · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Five factor consisting of Metabolic syndrome is closely linked by insulin resistance. Until now, several studies have been performed about effects of Korea red ginseng on hypertension, diabetes, and hyperlipidemia, but not metabolic syndrome. The investigators hypothesize that Korean red ginseng could improve each constituents of metabolic syndrome, arterial stiffness, and inflammatory markers. The aim of this study is to determine effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome.
Detailed description
The details of study objective are followed by these: * comparison of blood pressure before and after Korean red ginseng administration * comparison of metabolic indicator before and after Korean red ginseng administration * comparison of oxidative stress and inflammatory markers before and after Korean red ginseng administration * comparison of arterial stiffness before and after Korean red ginseng administration
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Korean red ginseng | 5 capsules (300 mg/capsule) three times everyday for 12 weeks |
| DIETARY_SUPPLEMENT | starch | 5 capsules three times everyday for 12 weeks |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2009-09-14
- Last updated
- 2012-02-27
- Results posted
- 2012-02-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00976274. Inclusion in this directory is not an endorsement.